Objectives: Extra-motor manifestations occur in 50% of patients with amyotrophic lateral sclerosis (ALS). These mainly concern cognition, emotional processing and behavior. Depression and anxiety are less frequent. Little is known about how these manifestations change as the disease progresses. Similarly, although cortical thinning has been well-documented at disease onset, there are scant data about cortical thinning over time and how this correlates with extra-motor manifestations. The present study therefore assessed cognitive, emotional and psychological state and cortical thinning in a group of patients with ALS at baseline and after a follow-up period.Methods: We assessed executive functions, facial emotion recognition, depressive and...
We aimed to quantitatively characterize progressive brain network disruption in Amyotrophic Lateral ...
Amyotrophic lateral sclerosis (ALS) has heterogeneous clinical features that could be translated int...
Amyotrophic lateral sclerosis (ALS) has heterogeneous clinical features that could be translated int...
International audienceIt is now well recognized that, in addition to motor impairment, amyotrophic l...
The aim of this study was to explore the pattern of regional cortical thickness in patients with non...
Amyotrophic lateral sclerosis (ALS) has heterogeneous clinical features that could be translated int...
Building on evidence for cognitive-behavioural change in people with Amyotrophic Lateral Sclerosis (...
The aim of this study was to explore the pattern of regional cortical thickness in patients with non...
Amyotrophic lateral sclerosis (ALS) has heterogeneous clinical features that could be translated in...
Introduction: Amyotrophic lateral sclerosis (ALS) is a severe neurodegenerative disease that causes ...
Objective: Examine whether cortical thinning is a disease-specific phenomenon across the spectrum of...
Amyotrophic lateral sclerosis (ALS) can be associated with a spectrum of cognitive and behavioural s...
Amyotrophic lateral sclerosis (ALS) is now universally recognized as a complex multisystem disorder ...
Objective: Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease with prominent motor s...
Objective: To understand the progressive nature of amyotrophic lateral sclerosis (ALS) by investigat...
We aimed to quantitatively characterize progressive brain network disruption in Amyotrophic Lateral ...
Amyotrophic lateral sclerosis (ALS) has heterogeneous clinical features that could be translated int...
Amyotrophic lateral sclerosis (ALS) has heterogeneous clinical features that could be translated int...
International audienceIt is now well recognized that, in addition to motor impairment, amyotrophic l...
The aim of this study was to explore the pattern of regional cortical thickness in patients with non...
Amyotrophic lateral sclerosis (ALS) has heterogeneous clinical features that could be translated int...
Building on evidence for cognitive-behavioural change in people with Amyotrophic Lateral Sclerosis (...
The aim of this study was to explore the pattern of regional cortical thickness in patients with non...
Amyotrophic lateral sclerosis (ALS) has heterogeneous clinical features that could be translated in...
Introduction: Amyotrophic lateral sclerosis (ALS) is a severe neurodegenerative disease that causes ...
Objective: Examine whether cortical thinning is a disease-specific phenomenon across the spectrum of...
Amyotrophic lateral sclerosis (ALS) can be associated with a spectrum of cognitive and behavioural s...
Amyotrophic lateral sclerosis (ALS) is now universally recognized as a complex multisystem disorder ...
Objective: Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease with prominent motor s...
Objective: To understand the progressive nature of amyotrophic lateral sclerosis (ALS) by investigat...
We aimed to quantitatively characterize progressive brain network disruption in Amyotrophic Lateral ...
Amyotrophic lateral sclerosis (ALS) has heterogeneous clinical features that could be translated int...
Amyotrophic lateral sclerosis (ALS) has heterogeneous clinical features that could be translated int...